Atria Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Atria Investments’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,662	Closed	-$913K	–	637
2020 Q1	$913K	Buy	4,662 +25	+0.5%	+$5.38K	0.07%	241
2019 Q4	$959K	Buy	+4,637	New	+$857K	0.03%	546
2019 Q3	–	Sell	-4,157	Closed	-$707K	–	908
2019 Q2	$707K	Sell	4,157 -1,169	-22%	-$139K	0.03%	494
2019 Q1	$627K	Buy	5,326 +298	+6%	+$30K	0.03%	472
2018 Q4	$461K	Buy	5,028 +706	+16%	+$71.6K	0.02%	530
2018 Q3	$486K	Buy	4,322 +78	+2%	+$8.24K	0.02%	600
2018 Q2	$391K	Buy	4,244 +237	+6%	+$23K	0.02%	648
2018 Q1	$400K	Buy	4,007 +398	+11%	+$42.9K	0.02%	583
2017 Q4	$338K	Buy	3,609 +676	+23%	+$63.9K	0.02%	602
2017 Q3	$298K	Buy	+2,933	New	+$256K	0.02%	608

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Atria Investments's LKFT Position: Q2 2020 in Review

Atria Investments sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2020, closing a stake of 4,662 shares — an estimated $913K sold.

Atria Investments first reported a position in LKFT in Q3 2017 and held it in 10 quarters. The position peaked at $959K in Q4 2019. 143 funds tracked by Wall St. Rank hold LKFT as of Q2 2020.

Atria Investments reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Atria Investments sold 4,662 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2020, an estimated $913K.
Atria Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2017 and held it in 10 quarters.
Atria Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $959K in Q4 2019.
143 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2020.

Based on Atria Investments's 13F filing for Q2 2020, filed 13 Aug 2020.